Status: current, Defined. Date: 30-Apr 2017. Module: Australian Medicines Terminology module
Descriptions:
Id | Description | Lang | Type | Status | Case? | Module |
3918271000168114 | Candesartan HCTZ 16/12.5 (DRLA) (candesartan cilexetil 16 mg + hydrochlorothiazide 12.5 mg) tablet (trade product unit of use) | en | Fully specified name | Active | Case sensitive | Australian Medicines Terminology module |
3918281000168112 | Candesartan HCTZ 16/12.5 (DRLA) tablet | en | Synonym | Active | Case sensitive | Australian Medicines Terminology module |
Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
Candesartan HCTZ 16/12.5 (DRLA) tablet, 30, blister pack | has TPUU | True | Candesartan HCTZ 16/12.5 (DRLA) tablet | Inferred relationship | Some | 1 |
Candesartan HCTZ 16/12.5 (DRLA) tablet, 10, blister pack | has TPUU | True | Candesartan HCTZ 16/12.5 (DRLA) tablet | Inferred relationship | Some | 1 |
Candesartan HCTZ 16/12.5 (DRLA) tablet, 7 | has TPUU | True | Candesartan HCTZ 16/12.5 (DRLA) tablet | Inferred relationship | Some | 1 |
Candesartan HCTZ 16/12.5 (DRLA) tablet, 30 | has TPUU | True | Candesartan HCTZ 16/12.5 (DRLA) tablet | Inferred relationship | Some | 1 |
Candesartan HCTZ 16/12.5 (DRLA) tablet, 10 | has TPUU | True | Candesartan HCTZ 16/12.5 (DRLA) tablet | Inferred relationship | Some | 1 |
Candesartan HCTZ 16/12.5 (DRLA) tablet, 7, blister pack | has TPUU | True | Candesartan HCTZ 16/12.5 (DRLA) tablet | Inferred relationship | Some | 1 |
Reference Sets
Trade product unit of use reference set